An open-label extension of two Phase III studies evaluating long-term efficacy of FMX101 4% minocycline foam for the treatment of acne vulgaris

Authors
Category Primary study
JournalJournal of Clinical and Aesthetic Dermatology
Year 2020
This article has no abstract
Epistemonikos ID: 927ffd540dbc37cba4a940be8cdfc98de4b1dc7b
First added on: Feb 12, 2025